INS and obesity due to melanocortin 4 receptor deficiency: The therapeutic mechanisms underpinning these improvements are poorly understood based upon the available studies, though the theoretical advantage to these medications may predominantly be weight loss in the setting of overweight/obesity, which may improve insulin sensitivity.